EPISODE · Jun 9, 2024 · 28 MIN
week of june 10: Greg Kunst - Aurion Biotech
from the weekly seattle
Top Stories1. Microsoft CEO leaves Starbucks boardGeekwire article2. Seattle startup wins lawsuit against BoeingSeattle Times article3. VC backed biotech Vilya raises $71MGeekwire article4. Lightrail SLU location debateOpinion 1: The Stranger articleOpinion 2: PSBJ article5. New record store on VashonSeattle Times articleAbout guest co-host Greg Kunst - Founder & CEO, Aurion Biotech:Greg Kunst founded Aurion Biotech which is a company that develops cell therapies for the treatment of serious eye disorders. He is on the board of Pr3vent, Inc tackling vision health for babies. He's strategic advisor for Oculogica. Prior to this, he held leadership positions at Glockos Corporation and Alcon, both companies tackling eye health.Host Rachel Horgan:Rachel is an independent event producer, emcee and entrepreneur. She worked for the Business Journal for 5 years as their Director of Events interviewing business leaders on stage before launching the weekly podcast. She earned her communication degree from the University of San Diego.Contact:Email: [email protected]Instagram: @theweeklyseattleWebsite: www.theweeklyseattle.com
Embed this episode
What this episode covers
Top Stories 1. Microsoft CEO leaves Starbucks board 2. Seattle startup wins lawsuit against Boeing 3. VC backed biotech Vilya raises $71M 4. Lightrail SLU location debate 5. New record store on Vashon
NOW PLAYING
week of june 10: Greg Kunst - Aurion Biotech
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.